CP Knowledge Centre > Demonstration > Technology type 

Welcome to CP Knowledge Centre

CP Knowledge Centre: Login | More details | Subscribe now

As a CP Knowledge Centre subscriber you will have access to the technology type collaboration and licensing reports listed below. All reports are updated on a rolling six month schedule, ensuring you always have access to the latest deals:

• Global Antibiotics Collaboration and Licensing Deals
• Global Antibody Collaboration and Licensing Deals
• Global Artificial Intelligence (AI) Collaboration and Licensing Deals
• Global Bioinformatics Collaboration and Licensing Deals
• Global Biomarker Collaboration and Licensing Deals
• Global Biosimilars Collaboration and Licensing Deals
• Global Cancer Diagnostics Collaboration and Licensing Deals
• Global Companion Diagnostics Collaboration and Licensing Deals
• Global Diagnostics Collaboration and Licensing Deals
• Global Diagnostic Imaging Collaboration and Licensing Deals
• Global Molecular Diagnostic Collaboration and Licensing Deals
• Global Drug Delivery Collaboration and Licensing Deals
• Global Gene Therapy Collaboration and Licensing Deals
• Global Gene Editing Collaboration and Licensing Deals
• Global Genomics Collaboration and Licensing Deals
• Global Microbiome Collaboration and Licensing Deals
• Global Monoclonal Antibodies Collaboration and Licensing Deals
• Global Cancer Monoclonal Antibodies Collaboration and Licensing Deals
• Global Pharmacogenomics Collaboration and Licensing Deals
• Global Precision Medicine Collaboration and Licensing Deals
• Global Proteomics Collaboration and Licensing Deals
• Global Regenerative Medicine Collaboration and Licensing Deals
• Global Stem Cell Collaboration and Licensing Deals
• Global Vaccine Collaboration and Licensing Deals
• Global Cancer Vaccine Collaboration and Licensing Deals
• Global Infectious Vaccine Collaboration and Licensing Deals

View full report descriptions and table of contents

CP Knowledge Centre > Demonstration > Technology type

CP Knowledge Centre: Login | More details | Subscribe now